The U.S. Food and Drug Administration approved the use of Keytruda in combination with chemotherapy as a first-line treatment for advanced pleural mesothelioma on September 17, 2024. Keytruda, an ...

Keytruda is not chemotherapy. It’s a type of treatment called immunotherapy. It works with the body’s immune system, helping T cells fight cancer cells. With immunotherapy, the body’s immune system ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...

Before the latest perioperative nod in resectable disease, Keytruda has been approved in first-line metastatic head and neck cancer. (Angus Liu/Fierce Pharma) Merck & Co.’s Keytruda has become the ...

A personalized mRNA cancer vaccine combined with the immunotherapy Keytruda succeeded in a late-stage trial for the deadly skin cancer melanoma, its makers said Wednesday, potentially opening up a new ...

Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab/berahyaluronidase alfa) are prescription medicines for a type of lung cancer called non-small-cell lung ...

Most people take Keytruda for about 2 years, but this can change depending on how well it works and the side effects experienced. After stopping, it usually takes about 4 months for Keytruda to leave ...

Overview: Keytruda Qlex is a medicine that is used to treat many types of cancer. This medicine is given an injection under your skin. It works by helping your immune system attack cancer cells. This ...

Gilead Sciences (NASDAQ:GILD) announced Saturday that its antibody-drug conjugate Trodelvy, in combination with Merck’s (NYSE:MRK) immunotherapy Keytruda, cut the risk of disease progression or death ...

ASCENT-04 randomized PD-L1–positive, untreated mTNBC to sacituzumab govitecan–pembrolizumab versus chemo–pembrolizumab, yielding a 3.4-month median PFS improvement (HR 0.65). Front-loading an ...

Alteogen announced on September 18 that MSD's Keytruda SC (marketed as Keyject in Japan), a subcutaneous injection (SC) ...